Condition

Thoracic Neoplasms

ClinicalTrials.gov condition label

Clinical trials41
Recruiting8
Common interventions25
Lead sponsors shown15

Clinical trials

41 shown
Pharmacologic Therapies to Mitigate Radiation- Associated Heart DiseaseNCT07685938 · 2026-08-12
RECRUITING
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC PatientsNCT07242547 · 2026-05-20
RECRUITING
Post-operative Medium Chain Triglyceride Diet May Reduce Hospital Stay Following Lung ResectionNCT07159659 · 2026-03-19
RECRUITING
PALACE: Cemiplimab Trial According to ctDNA LevelsNCT06917573 · 2025-07-29
RECRUITING
Post-line Treatment With Teniposide for c-Myc-driven Extensive-stage Small Cell Lung CancerNCT06758700 · 2025-02-07
RECRUITING
Early Intervention Strategies for Lung CancerNCT06988943 · 2024-06-25
RECRUITING
The Effects of a Family-Centered Tai Chi Exercise on Lung Function and Mental Health of Patients After Thoracoscopic SurgeryNCT06104774 · 2023-10-20
RECRUITING
Erector Spinae Block for Thoracic SurgeryNCT05521789 · 2022-07-22
RECRUITING
Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) StudyNCT06494241 · 2024-11-22
ACTIVE_NOT_RECRUITING
SPSIPB vs SAPB for Thoracoscopic SurgeryNCT06546839 · 2024-08-10
COMPLETED
Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLCNCT06376084 · 2024-07-23
ACTIVE_NOT_RECRUITING
A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLCNCT06177925 · 2023-12-10
UNKNOWN
Real World Registry for Use of the Ion Endoluminal SystemNCT06004440 · 2023-09-21
ACTIVE_NOT_RECRUITING
Pain Control After VATS Anatomical Pulmonary ResectionsNCT05993273 · 2023-04-05
COMPLETED
(HARMONY) Study of BLU-701 in EGFR-mutant NSCLCNCT05153408 · 2022-01-13
TERMINATED
(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLCNCT04862780 · 2021-06-29
TERMINATED
Atezolizumab Plus Induction Chemotherapy Plus CT-radiotherapy. (APOLO)NCT04776447 · 2021-06-16
COMPLETED
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid TumorsNCT04644315 · 2021-05-24
TERMINATED
Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid CarcinomaNCT04725448 · 2021-04-06
UNKNOWN
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLCNCT04697446 · 2020-12-01
UNKNOWN
Improving Cancer On-treatment Symptom ManagementNCT04589247 · 2020-11-16
COMPLETED
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)NCT04222972 · 2020-07-24
TERMINATED
Sintilimab (IBI308) in the Neoadjuvant Treatment of Patients With Resectable II-IIIA NSCLCNCT04371796 · 2020-05-10
UNKNOWN
Integrated Care Pathway in Oncology (PASSION)NCT04235556 · 2020-02-21
UNKNOWN
Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLCNCT04133337 · 2019-11-01
UNKNOWN
Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLCNCT03389256 · 2018-12-30
UNKNOWN
A Study of SHR-1210 in Combination With Pemetrexed and Carboplatin in Subjects With Non-squamous NSCLCNCT03134872 · 2017-05-12
COMPLETED
International Lung Screen Trial (ILST)NCT02871856 · 2017-04-05
UNKNOWN
Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsNCT03037385 · 2017-03-17
COMPLETED
Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid TumorsNCT02909452 · 2016-09-20
COMPLETED
Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid TumorsNCT02897778 · 2016-08-24
COMPLETED
Identifying Genomic Mutations of Multiple Primary Lung Cancers by Circulating Tumor DNANCT02833467 · 2015-01-01
UNKNOWN
A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive CancersNCT02188563 · 2014-05-01
COMPLETED
A Multimodality Image-guided System for Peripheral Lung Cancer Diagnosis and TherapyNCT02111824 · 2014-01-05
TERMINATED
The EPIC Trial The Elderly Patient Individualized Chemotherapy TrialNCT03402048 · 2012-07-01
UNKNOWN
Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 MutationsNCT01024413 · 2009-07-01
COMPLETED
Postoperative Radiotherapy for Patients With IIIA (N2) Non-small Cell Lung CancerNCT00880971 · 2009-02-18
COMPLETED
Thoracic OncoGeriatric Assessment (TOGA) TrialsNCT00591981 · 2007-08-01
COMPLETED
Follow-up Modalities of Low Grade Precancerous Bronchial LesionsNCT00213603 · 2002-04-01
COMPLETED
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal InjuryNCT00631839 · 2002-01-01
UNKNOWN
Expanded Access Program of Taletrectinib in Patients With Advanced or Metastatic ROS1-Positive NSCLCNCT06841874
NO_LONGER_AVAILABLE

Common interventions

CarboplatinDRUG7PemetrexedDRUG4ApatinibDRUG2EntinostatDRUG2GemcitabineDRUG2Nab-PaclitaxelDRUG2osimertinibDRUG2PaclitaxelDRUG2PembrolizumabDRUG2PlaceboDRUG2AdebrelimabDRUG1AI full-lung model interpretation systemDEVICE1AlectinibDRUG1AtezolizumabDRUG1Atorvastatin and LisinoprilDRUG1BevacizumabDRUG1BLU-701DRUG1BLU-945DRUG1Carboplatin/CisplatinDRUG1Care pathway unitBEHAVIORAL1CemiplimabDRUG1CisplatinDRUG1Comprehensive smoking cessation interventionOTHER1CryoanalgesiaPROCEDURE1Digital Health PlatformDEVICE1

Trial status mix

COMPLETED13
UNKNOWN11
RECRUITING8
TERMINATED5
ACTIVE_NOT_RECRUITING3
NO_LONGER_AVAILABLE1

Phase mix

PHASE212
NA7
PHASE17
PHASE35
PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.